Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Instill Bio (TIL)

Instill Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TIL
DateTimeSourceHeadlineSymbolCompany
21/03/202421:00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
14/02/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
13/02/202422:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
18/01/202412:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
16/01/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
16/01/202413:00GlobeNewswire Inc.Instil Bio Announces Strategic UpdateNASDAQ:TILInstill Bio Inc
11/01/202401:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
11/01/202400:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
08/12/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
05/12/202322:00GlobeNewswire Inc.Instil Bio Announces Effective Date of 1-for-20 Reverse Stock SplitNASDAQ:TILInstill Bio Inc
27/11/202312:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
13/11/202322:27Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:TILInstill Bio Inc
13/11/202322:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
13/11/202322:00GlobeNewswire Inc.Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
13/11/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
06/11/202312:00GlobeNewswire Inc.Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual MeetingNASDAQ:TILInstill Bio Inc
14/08/202312:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
14/08/202312:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/08/202312:00GlobeNewswire Inc.Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
26/06/202321:38GlobeNewswire Inc.Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual ConferenceNASDAQ:TILInstill Bio Inc
26/06/202321:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
14/06/202321:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
11/05/202312:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
11/05/202312:00GlobeNewswire Inc.Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
28/04/202321:37Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:TILInstill Bio Inc
24/04/202321:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TILInstill Bio Inc
10/04/202314:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TILInstill Bio Inc
31/03/202312:40Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TILInstill Bio Inc
31/03/202312:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
31/03/202312:00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TIL